Chugai Pharmaceutical's R&D expenditure 2013-2022
One of the main products developed by the company is "Actemra". As of this report, Actemra is the only biological product developed in Japan and was approved for sales in both the United States and Europe. Biological products are products made from various natural resources, such as sugars, proteins, or nucleic acids.